Endocrinology & Disorders

Endocrine Tumor Genetics

The Endocrine Tumor Genetics Program helps to identify and provide comprehensive, coordinated medical care for families that have a hereditary risk for endocrine tumors. Our program is a collaboration between the Center for Cancer Risk Assessment (CCRA) and Thyroid Associates at Massachusetts General Hospital, and includes specialists in both endocrinology and genetics. Patients with pathogenic variants in hereditary endocrine tumor genes are managed comprehensively with our team of endocrinologists and genetic counselors. We also provide risk assessment for patients interested in an evaluation for hereditary endocrine tumors. During the initial genetics consultation, family history is carefully reviewed. If your personal or family history suggests a possible genetic risk, we will discuss the option of genetic.